ArticleThe journal of headache and pain2026
Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling.
Min-Hua Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.